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OBJECTIVE
To test whether a weight loss program promotes greater weight loss, glycemic
control, and improved cardiovascular disease risk factors compared with control
conditions and whether there is a differential response to higher versus lower
carbohydrate intake.
RESEARCH DESIGN AND METHODS
This randomized controlled trial at two university medical centers enrolled 227
overweight or obese adults with type 2 diabetes and assigned them to parallel in-
person diet and exercise counseling, with prepackaged foods in a planned menu
during the initial phase, or to usual care (UC; two weight loss counseling sessions
and monthly contacts).
RESULTS
Relative weight loss was 7.4% (95% CI 5.7–9.2%), 9.0% (7.1–10.9%), and 2.5%
(1.3–3.8%) for the lower fat, lower carbohydrate, and UC groups (P < 0.001 in-
tervention effect). Glycemic control markers and triglyceride levels were lower in
the intervention groups compared with UC group at 1 year (fasting glucose 141
[95% CI 133–149] vs. 159 [144–174] mg/dL, P = 0.023; hemoglobin A1c 6.9% [6.6–
7.1%] vs. 7.5% [7.1–7.9%] or 52 [49–54] vs. 58 [54–63] mmol/mol, P = 0.001;
triglycerides 148 [134–163] vs. 204 [173–234] mg/dL, P < 0.001). The lower versus
higher carbohydrate groups maintained lower hemoglobin A1c (6.6% [95% CI
6.3–6.8%] vs. 7.2% [6.8–7.5%] or 49 [45–51] vs. 55 [51–58] mmol/mol) at 1 year
(P = 0.008).
CONCLUSIONS
The weight loss program resulted in greater weight loss and improved glycemic
control in type 2 diabetes.
More than two-thirds of adults in the U.S. (69.2%) are overweight or obese (1). Of
the many health conditions that are associated with obesity, type 2 diabetes is
among the most prevalent (2). Achieving and maintaining a healthy body weight
is a primary strategy for the management of type 2 diabetes (3). Participation in a
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face-to-face tailored lifestyle interven-
tion that involves diet modification, in-
creased physical activity, and behavior
therapy, such as that of the Action for
Health in Diabetes (Look AHEAD) trial
intervention, can result in a degree of
weight loss for overweight patients
with diabetes that improves glycemic
control and cardiovascular disease risk
factors (4,5). However, most overweight
or obese individuals with type 2 diabe-
tes do not receive this degree of support
for changes in diet and physical activity
to promote weight loss in their clinical
care partly due to constraints of time
and training for most health-care pro-
viders and clinicians (6,7).
The intervention in the present study
was a commercial weight loss program
that includes one-to-one behavioral
counseling, a low-energy-density diet,
prepackaged foods, and increased phys-
ical activity. In a randomized clinical tri-
al, the programwas shown to effectively
promote weight loss in generally
healthy adults compared with a usual
care (UC) control condition, resulting in
an average 1-year weight loss of ;10%
and an average 2-year weight loss of
;7% (8). The effectiveness of this mul-
tifaceted intervention has not been pre-
viously examined in a randomized trial
targeting individuals with type 2 diabetes
who have high rates of cardiovascular dis-
ease morbidity and mortality as well as a
high risk for secondary and tertiary med-
ical complications if glycemic control is
not achieved and maintained.
Although a deficit in total energy in-
take relative to expenditure is the most
critical dietary factor that determines
weight loss, increasing evidence sug-
gests that macronutrient composition
of the diet may also influence weight
loss and metabolic response (9). In a
few previous studies, effects on athero-
genic dyslipidemia and glycemic control
have been observed to be more favor-
able with a lower versus higher carbo-
hydrate diet, after adjusting for weight
loss, in individuals with insulin resis-
tance or type 2 diabetes (10–12).
The first aim of the present study was
to test in a randomized controlled trial
whether participation in this structured
weight loss program promotes greater
1-year weight loss and maintenance in
overweight or obese adults with type 2
diabetes compared with UC conditions.
A secondary aim was to describe the
effect of participating in the program
(vs. UC) on markers of glycemic control
(fasting glucose, hemoglobin A1c [HbA1c]),
cardiovascular disease risk factors (tri-
glyceride, HDL cholesterol, C-reactive
protein [CRP] levels), cardiopulmonaryfit-
ness, quality of life, and plasma caroten-
oids (a biomarker of vegetable and fruit
intake). An exploratory aim was to ex-
amine whether there is a differential
response to dietary macronutrient com-
position (higher vs. lower carbohydrate)
in weight change and markers of glyce-
mic control and cardiovascular disease
risk.
RESEARCH DESIGN AND METHODS
Study Participants
Men and womenwere recruited and en-
rolled at two study sites (University of
California, San Diego [UCSD]; University
of Minnesota, Minneapolis). Partici-
pants were recruited through word of
mouth, direct marketing letters mailed
to large cohorts, radio advertise-
ments, local e-mail subscription services,
ClinicalTrials.gov, social media, and
flyers. Eligibility criteria were a history
of type 2 diabetes confirmed by a physi-
cian; aged$18 years; BMI 25–45 kg/m2;
not pregnant or breastfeeding or plan-
ning to become pregnant in the next
year; willing to participate in any of the
study diet arms over a 1-year period; no
eating disorders, food allergies, or food
intolerances; no history of bariatric sur-
gery; and willing and able to perform a
step test for assessing cardiopulmonary
fitness. Current active involvement in
another diet intervention study or orga-
nized weight loss program; weight loss
.10 lb in the past 3 months; or having a
history or presence of a significant psy-
chiatric disorder or any other condition
that, in the investigator’s judgment,
would interfere with participation in
the trial disqualified participants. Other
exclusion criteria were HbA1c .11%
(97mmol/mol), fasting triglyceride level
.600 mg/dL, and serum creatinine level
$1.4 mg/dL (women) or 1.5 mg/dL
(men).
Participants were randomly assigned
to a weight loss program with a higher
carbohydrate, lower fat (LF) diet plan; a
weight loss program with a lower carbo-
hydrate, higher fat (LC) diet plan; or a UC
program (Supplementary Fig. 1). Ran-
domization was stratified by study site
and BMI using a web-based application
with a sequence generated by the
study statistician. Participants were
reimbursed $25 for each data collection
clinic visit, with incremental increases
over the course of the study to compen-
sate for rising fuel costs, but no compen-
sation was provided for participation in
the intervention or counseling sessions.
Institutional review boards at both uni-
versities approved the study protocol,
and all participants provided written in-
formed consent.
Intervention
Participants in the two commercial
weight loss program arms of the study
received weight loss counseling and all
program materials free of charge, in-
cluding prepackaged foods. Three en-
trees and one to two snacks were
provided for 7 days/week during the
initial weight loss phase (months 1–6)
and for 5 days/week during a transition
phase (months 7–9), and one entree and
one snack daily was provided, as de-
sired, during the maintenance phase
(months 10–12). Participants were en-
couraged, especially during the initial
period, to follow the menu plan with
prepackaged foods (41–76% of energy).
The prepackaged foods provided more
than one-half to two-thirds of energy
intake for most participants and some-
what less for those at higher levels of
dietary energy prescription during the
initial period. Grocery foods, such as
vegetables, fruit, cereal/grain products,
dairy products, lean meat, and unsatu-
rated fat sources, were recommended
to achieve the total prescribed energy
and macronutrient intake. Participants
also were provided guidance for how
to choose grocery and restaurant foods
that would meet the meal plan to ac-
commodate special occasions and other
needs.
One-to-one counseling sessions with
trained program staff were offered for
the 1-year period, with follow-up tele-
phone and website/message board
availability. Weekly counseling visits
were recommended during the first 9
months after which participants had
the option to move from weekly to
biweekly or monthly consultations.
Program materials encouraged basic
diabetes self-management strategies,
such as monitoring of blood glucose
and symptoms of hypoglycemia and
hyperglycemia, as well as tracking of
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food intake and physical activity.
Counselors were not blinded to the
identity of study participants. Pre-
pared foods, program materials, prod-
ucts, and counselors were provided by
Jenny Craig, Inc. (Carlsbad, CA).
Both commercial weight loss program
diet meal plans were reduced in energy
relative to expenditure (typically 1,200–
2,000 kcal/day). The LF diet plan pro-
vided 60% energy from carbohydrates,
20% from fat, and 20% from protein. The
LC diet plan provided 45% energy from
carbohydrates, 30% from fat, and 25%
from protein. Nutrient content of the
two diet meal plans was otherwise sim-
ilar. In both diet meal plans, strategies
to reduce energy density of the diet,
such as incorporating vegetables and
water-rich foods in meals and snacks,
were encouraged.
Increased physical activity was en-
couraged, with the goal of 30 min of
physical activity on $5 days/week. Pro-
gram materials and counseling ad-
dressed attitudes about weight, food,
and physical activity, and materials in-
cluded recipes, guidance for eating in
restaurants, digital videos and exercise
equipment to increase physical activity,
and online education and support.
After randomization and at 6 months,
participants assigned to UC received a
1-h individual weight loss counseling
session with a dietitian. In the first ses-
sion, participants were advised to con-
sume a deficit of 500–1,000 kcal/day to
achieve a weight loss of 10% of initial
weight. Participants were encouraged
to use web-based tracking programs
that guide toward the macronutrient
distribution recommended in the Die-
tary Guidelines for Americans (20–35%
[average 30%] of energy from fat, 45–
65% [average 55%] from carbohydrates,
and 10–35% [average 15%] from pro-
tein) (13). Counseling and print materi-
als encouraged strategies and skills for
weight loss and maintenance (e.g., esti-
mating portion sizes, self-monitoring).
This session was followed by monthly
check-in through e-mail or telephone
calls, and progress was discussed in
the follow-up counseling session. Par-
ticipants in UC also received a standard-
ized checklist of recommendations for
general diabetes care, including regular
glucose monitoring, awareness of
symptoms of hypoglycemia and hypergly-
cemia, and the importance of adherence
to prescribed medications and good hy-
giene practices.
Outcomes and Follow-up
At data collection clinic visits, weight,
waist circumference, height (baseline
only), and blood pressure were mea-
sured, and questionnaires [the Beck
Depression Inventory (14), 36-item
short-form health survey quality-of-
life questionnaire (15), and Godin Lei-
sure-Time Exercise Questionnaire (16)]
were collected by institution research
staff who usually were unblinded. The
3-min step test was used to assess aero-
bic fitness. This test measures heart rate
during the first 30 s of recovery from
stepping, and although less accurate
than measuring VO2max, the test has high
reliability and is sensitive to change (17).
Fasting ($6 h) blood samples were
collected at each clinic visit. Glucose,
cholesterol, triglyceride, HDL choles-
terol, and creatinine (at baseline screen-
ing visit only) levels weremeasured with
the Kodak Ektachem Analyzer system
(Johnson & Johnson Clinical Diagnostics,
Rochester, NY). LDL cholesterol values
were calculated by the Friedewald equa-
tion (18). The ADVIA Centaur assay, a
double-antibody immunoassay with
chemiluminescent detection, was used
for insulin quantification. HbA1c was
measured in washed erythrocytes with
ion exchange high-performance liquid
chromatography (D10 System, Bio-Rad
Laboratories, Hercules, CA). High-sensi-
tivity CRP was assayed using a polysty-
rene-enhanced turbidimetric in vitro
immunoassay (19,20). Plasma caroten-
oid concentrations, an indicator of fruit
and vegetable consumption, were mea-
sured by high-performance liquid chro-
matography (21).
Statistical Analysis
Weight change, the primary study out-
come, was analyzed as intention to
treat, with baseline substitution for
missing data. This approach assumes
that participants who did not complete
clinic visits or dropped out returned to
their baseline weight and is recommen-
ded based on usual recidivism after
weight loss (22). Change over time
(weight, laboratory values, blood pres-
sure, and psychosocial variables) was
examined in longitudinal mixed models,
based on an interaction between study
group and time, and controlled for sex.
We also examined weight data for com-
pleters, recognizing a likely bias because
dropouts may be less adherent and may
exhibit weight rebound. To improve
normality of distributions, log transfor-
mation was applied to laboratory values
in analysis, but untransformed means
are presented in text and tables for
ease of interpretation. Models for glu-
cose, HbA1c, and insulin were controlled
for use of insulin and other diabetes
medications. A subject-specific inter-
cept, representing baseline levels of
each modeled outcome, was included
as a random effect in each model. Pro-
portions of participants who stopped or
decreased medications were compared
with Fisher exact test. Statistical signifi-
cance was two-sided without adjustment
for multiple comparisons. All analyses
were conducted with SAS 9.3 (SAS Insti-
tute, Cary, NC) statistical software.
Power calculations were based on
data from a previous clinical trial of the
weight loss program (8) and biochemical
laboratory data in individuals with dia-
betes (4). Usingmean (SD) effect sizes of
6.8 (8.8) in the intervention groups and
2.0 (7.2) in the control group, there was
90% power for the primary aim with 75
participants per arm and a dropout rate
of up to 20%. There was also 90% power
to discern between-group HbA1c differ-
ences of 0.5% (6 mmol/mol).
RESULTS
The study sample comprised 227 men
and women aged 24–75 years (mean
56 years) (Table 1) who were recruited
between March and August 2012. Dur-
ing the study period, two participants
(one LF and one LC) died, one of cardio-
vascular disease before the 6-month
visit and the other of cancer before the
12-month visit. Primary outcome data
were obtained at study end from 90%
of the participants who were random-
ized. Attrition did not differ by study
group (Supplementary Fig. 1). Over the
year of active involvement, counseling
visits in the weight loss program inter-
vention groups ranged from 1 to 69,
with a median of 41 visits.
At baseline, mean (SD) weight was
105.5 (17.6) kg. At 6 months, those in
the LF group had reduced initial weight
by 8.6% (95% CI 7.2–10.0%), those in the
LCgroup by 10.4% (8.9–12.0%), and those
in UC group by 2.3% (1.3–3.2%) (Table 2).
Participants in the intervention arms lost
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more weight than those in the UC arm
(10.3 [95% CI 9.2–11.5] vs. 2.8 [1.6–4.1]
kg, P, 0.001). At study end, maintained
weight loss was greater in the interven-
tion arms (8.2% of initial weight) than in
the UC arm (2.5% of initial weight, P ,
0.001). The LF and LC groups did not dif-
fer in weight loss at 12 months in the
intention-to-treat analysis, although
among the completers, LC lost more
weight than LF (10.2 vs. 7.9%, P =
0.035). A majority (86 of 149) of partic-
ipants in the weight loss program main-
tained at least a 5% loss of initial body
weight at study end compared with less
than one-quarter (18 of 76) of UC partic-
ipants (P, 0.001). At study end, a$10%
weight reduction was achieved by 38%
of the weight loss program participants
(57 of 149) and 9% of the UC participants
(7 of 76, P, 0.001). At 6months, diastolic
blood pressure was lower in the weight
loss program participants (77 [95% CI
75–79] mmHg) than in the UC partici-
pants (82 [78–85] mmHg, P = 0.006).
At 6 months, participants in both
weight loss program groups but not
in the UC group reported increased
moderate/vigorous physical activity of
;1.5 h more than their baseline levels
or than UC (P, 0.001 for each) (Table 2).
Participants in all three groups had lower
recovery heart rates after the step test at
6 months than they had at baseline (P,
0.001). Weight loss program participants
also had lower depression scores thanUC
participants (5 [95%CI 4–6] vs. 7 [5–9], P =
0.009) and better physical quality-of-life
scores (80 [77–83] vs. 72 [67–78], P =
0.005) at 6 months (Table 2).
None of the laboratory measures
differed among the three groups at
study entry. However, glycemic control
markers (glucose, HbA1c, and insulin)
and triglyceride levels were lower in
both LF and LC than in UC at 6 months
(glucose 132 [95% CI 126–138] vs. 148
[137–160] mg/dL, P = 0.006; HbA1c 6.4%
[6.3–6.6%] vs. 7.2% [6.8–7.6%] [or 46
(45–49) vs. 55 (51–60) mmol/mol], P ,
0.001; insulin 21 [18–24] vs. 29 [21–37]
mIU/mL, P = 0.006; triglycerides 143
[130–157] vs. 181 [160–203] mg/dL,
P , 0.001), and these differences were
sustained at 12 months (glucose 141
[133–149] vs. 159 [144–174] mg/dL,
P = 0.023; HbA1c 6.9% [6.6–7.1%] vs.
7.5% [7.1–7.9%] or 52 [49–54] vs. 58
[54–63] mmol/mol, P = 0.001; insulin
21 [18–25] vs. 25 [20–30] mIU/mL, P =
0.016; triglycerides 148 [134–163] vs.
204 [173–234] mg/dL, P, 0.001) (Table
3). Participants in the LC diet group had
lower mean glucose concentration (P =
0.037) and HbA1c (P = 0.024) than those
in the LF diet group at 6 months, and
the HbA1c difference between LC and
LF was sustained at 12 months (P =
0.021) (Table 3). At study end, 62% of
weight loss program participants (83 of
133) and 45% of the UC participants (30
of 66) met the recommended HbA1c
general goal of ,7% (53 mmol/mol)
for diabetes care (71% [47 of 66] and
54% [36 of 67] of LC and LF participants,
respectively; P = 0.037) (23). Total and
LDL cholesterol levels did not differ be-
tween the groups at either follow-up
time point. Compared with the UC
group, the weight loss program groups
had higher HDL cholesterol and total
carotenoid levels and lower CRP levels
at study end (Table 3).
Self-reported medication use changed
during the course of the study (Table 4).
Eighteen percent of the participants (n =
41) used insulin at study entry, with a
mean duration of 4 years. Of these par-
ticipants, 72% (21 of 29) in the weight
loss program groups decreased or dis-
continued insulin use by study end
compared with 8% (1 of 12) in the UC
group. Similarly, oral hypoglycemic,
cholesterol-lowering, and blood pres-
sure medication use was reduced or
discontinued more often among the
weight loss program participants than
among the UC participants (P = 0.007,
0.024, and 0.032, respectively). Only
4% of study participants reported any
use of glucon-like peptide agonists dur-
ing the trial, among whom three sub-
jects stopped and two started these
medications.
CONCLUSIONS
A commercially available structured
weight loss program involving diet mod-
ification, increased physical activity, and
behavioral counseling produced weight
loss and improved glycemic control in
type 2 diabetes comparable with that
achieved in a well-funded clinical trial
(4). At 1 year, participants in the weight
loss program intervention lost 8.2% of
initial weight compared with a 2.5%
weight loss in the control group. Several
cardiovascular disease risk factors also
Table 1—Characteristics of participants at study entry
LF (n = 74) LC (n = 77) UC (n = 76)
Age (year) 55.5 (9.2) 57.3 (8.6) 56.8 (9.3)
Sex
Male 39 (52.7) 40 (52.0) 32 (42.1)
Female 35 (47.3) 37 (48.1) 44 (57.9)
Race/ethnicity
Non-Hispanic white 59 (79.7) 63 (81.8) 59 (77.6)
Hispanic 4 (5.4) 6 (7.8) 7 (9.2)
African American 7 (9.5) 2 (2.6) 4 (5.3)
Asian 4 (5.4) 4 (5.1) 2 (2.6)
Multiple and other* 0 2 (2.6) 4 (5.3)
Clinical site
UCSD 36 (48.7) 37 (48.1) 37 (48.7)
University of Minnesota 38 (51.4) 40 (52.0) 39 (51.3)
BMI
Overweight (25–29.99 kg/m2) 4 (5.4) 6 (7.8) 6 (7.9)
Obese I (30–34.99 kg/m2) 28 (37.8) 27 (35.1) 26 (34.2)
Obese II (35–39.99 kg/m2) 24 (32.4) 26 (33.8) 26 (34.2)
Obese III (40–45 kg/m2) 18 (24.3) 18 (23.4) 18 (23.7)
Comorbidities
Current smoking 5 (6.8) 1 (1.3) 2 (2.7)
History of invasive cancer 5 (6.8) 3 (3.9) 3 (4.0)
Bone or joint problems 14 (18.9) 16 (20.8) 10 (13.2)
Hypertension 46 (62.2) 60 (77.9) 57 (75.0)
High cholesterol 46 (62.2) 54 (70.1) 56 (73.7)
Coronary artery disease (angina, MI) 5 (6.8) 4 (5.2) 1 (1.3)
Asthma 9 (12.2) 8 (10.4) 2 (2.6)
Diabetes medication use (year) 6 (6) 5 (5) 5 (5)
Data are mean (SD) or n (%). MI, myocardial infarction. *Includes those who reported being part
Native American, part Asian, part Hispanic, or fully Pacific Islander/Native Hawaiian.
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were favorably improved at 1 year in the
weight loss intervention participants
compared with control participants.
Data were available from 90% of partic-
ipants at study end, so little ambiguity
exists in drawing conclusions from this
study, which is not typical for weight
loss trials. Structured, intensive weight
loss and diet interventions are recog-
nized as useful and recommended for
managing type 2 diabetes, but the chal-
lenge of delivering this type of interven-
tion in clinical practice is a recognized
problem in diabetes management (3).
Findings from the current study suggest
that clinicians can refer patients to and
use a commercial weight loss program
that is evidence based to optimize
weight loss and diabetes care.
Optimal macronutrient distribution
of weight loss diets has not been estab-
lished. The Institute of Medicine (24),
American Diabetes Association (3), and
American Heart Association (AHA) (25)
recommend the following spectrum of
dietary composition for the general
adult population: 20–35% of energy
(AHA 25–35%) from fat; 45–65% of en-
ergy (AHA 50–60%) from carbohydrates;
and 10–35% of energy (at least 0.8 g/kg)
from protein. Dietary carbohydrate in-
take is the primary determinant of blood
glucose values, and evidence suggests
that the quantity, and perhaps quality,
of carbohydrate sources can influence
metabolic response to a weight loss
diet in diabetes management (26,27).
The lower and higher carbohydrate di-
ets studied in this trial are both within
the range of recommended intake. The
moderately reduced level of carbohy-
drate intake examined as an exploratory
aim in this study is likely to be sustainable,
which is a concernwith low-carbohydrate
diets in both the general population
(28,29) and patients with type 2 diabe-
tes (11).
In the Look AHEAD study (N =
5,145), a weight loss and physical activ-
ity intervention that included liquid
meal replacements and the option of
weight loss medications, an average
weight loss of 8.6% of initial weight at
1 year was achieved (4). In Look AHEAD,
the mean HbA1c at 1 year was reduced
from 7.3 to 6.6% (56–49 mmol/mol) in
the intervention group compared with
7.2% (55 mmol/mol) in the diabetes
education control group. A few previ-
ous studies compared the effect of a
T
a
b
le
2
—
B
o
d
y
m
e
a
su
re
m
e
n
ts*
a
n
d
b
lo
o
d
p
re
ssu
re
,
b
e
h
a
vio
ra
l,
a
n
d
p
sy
ch
o
so
cial
m
e
a
su
re
s
†
LF
LC
U
C
B
aselin
e
6
m
o
n
th
s
12
m
o
n
th
s
B
aselin
e
6
m
o
n
th
s
12
m
o
n
th
s
B
aselin
e
6
m
o
n
th
s
12
m
o
n
th
s
W
eigh
t
ch
an
ge
(%
)
2
8.6
(5.9)
2
7.4
(7.6)
2
10.4
(6.9)
2
9.0
(8.4)
2
2.3
(4.2)
2
2.5
(5.5)
P
valu
e
‡
,
0.001
,
0.001
W
eigh
t
(kg)
105.4
(17.8)
96.5
(17.5)
97.7
(18.0)
106.4
(18.3)
95.0
(17.9)
96.7
(19.7)
104.6
(16.9)
102.2
(17.3)
101.9
(17.4)
P
valu
e
‡
0.87
,
0.001
0.005
B
M
I
(kg/m
2)
36.2
(4.3)
33.2
(4.4)
33.5
(4.7)
36.2
(4.7)
32.4
(4.8)
33.0
(5.5)
36.3
(4.4)
35.5
(4.7)
35.4
(4.6)
P
valu
e
‡
0.86
,
0.001
0.001
W
aist
(cm
)
119.9
(11.5)
112.7
(11.8)
113.2
(13.3)
121.3
(12.3)
111.8
(13.3)
112.3
(14.6)
119.9
(11.9)
117.7
(13.1)
117.1
(13.0)
P
valu
e
‡
0.93
,
0.001
0.007
Systo
lic
b
lo
o
d
p
ressu
re
(m
m
H
g)
133
(15)
125
(14)
127
(16)
131
(19)
125
(77)
127
(15)
133
(15)
129
(16)
126
(14)
P
valu
e
‡
0.66
0.024
0.72
D
iasto
lic
b
lo
o
d
p
ressu
re
(m
m
H
g)
84
(11)
77
(9)
77
(10)
82
(12)
76
(11)
78
(11)
83
(11)
82
(12)
78
(12)
P
valu
e
‡
0.97
0.006
0.99
M
o
d
erate/vigo
ro
u
s
activity
(h
/w
eek)
1.8
(2.4)
3.4
(3.6)
3.1
(3.6)
2.2
(2.5)
3.6
(3.2)
3.8
(3.9)
1.8
(2.6)
1.8
(2.1)
2.0
(1.9)
P
valu
e
‡
0.75
,
0.001
0.003
B
D
I
7
(6)
5
(5)
4
(4)
6
(5)
5
(7)
5
(7)
7
(6)
7
(8)
6
(7)
P
valu
e
‡
0.95
0.009
0.28
SF-36
Ph
ysical
78
(15)
80
(17)
82
(15)
80
(15)
80
(19)
80
(21)
80
(15)
72
(22)
80
(16)
P
valu
e
‡
0.70
0.005
0.52
M
en
tal
80
(16)
82
(14)
82
(14)
79
(17)
79
(18)
74
(20)
82
(16)
80
(17)
80
(18)
P
valu
e
‡
0.44
0.049
0.72
D
ata
are
m
ean
(SD
).
B
D
I,B
eck
D
ep
ressio
n
In
ven
to
ry;
SF-36,36-item
sh
o
rt
fo
rm
h
ealth
su
rvey
q
u
ality-o
f-life
q
u
estio
n
n
aire.*W
eigh
t,B
M
I,an
d
w
aist
d
ata
are
an
alyzed
as
in
ten
tio
n
to
treat
w
ith
b
aselin
e
su
b
stitu
tio
n
.†B
lo
o
d
p
ressu
re,b
eh
avio
ral,an
d
p
sych
o
so
ciald
ata
w
ere
an
alyzed
fo
rth
o
se
w
ith
m
easu
red
d
ata
(m
issin
g
d
ata
at6
m
o
n
th
s:n
=
2
LF,n
=
2
LC
,n
=
12
U
C
;m
issin
g
d
ata
at12
m
o
n
th
s:n
=
7
LF,n
=
9
LC
,n
=
8
U
C
).
‡P
valu
es
fo
r
d
ifferen
ces
b
etw
een
U
C
an
d
aggregated
w
eigh
t
lo
ss
p
ro
gram
p
articip
an
ts,as
sp
ecifi
ed
in
th
e
p
rim
ary
sp
ecifi
c
aim
,cam
e
fro
m
lo
n
gitu
d
in
alm
ixed
m
o
d
els
co
n
tro
lled
fo
r
sex.
care.diabetesjournals.org Rock and Associates 1577
very-low-carbohydrate diet (20–24% of
energy) to the more conventional low-
fat diet in individuals with type 2 dia-
betes. Similar weight loss but more
favorable effects on lipids and glycemic
control (although often transient) were
observed, but declining adherence
over even 1 year of study involvement
and a higher attrition rate constrain
interpretation of the results (10,11,30).
The response to another commer-
cially available weight loss program
that includes prepackaged foods was ex-
amined in 100 obese patients with
type 2 diabetes in a 6-month study
(31). Participants assigned to the weight
loss program lost 7.8% of initial weight
compared with 2.1% in a control group
provided general diabetes management
education, and HbA1c declined from 7.6
to 6.9% (60–52 mmol/mol) vs. 7.9–7.5%
(63–58 mmol/mol) in the control group.
A role for meal replacement products,
which are composite food products
(beverages, snack bars, or ready-to-mix
powders) has been proposed for pro-
moting weight loss in diabetes manage-
ment (32). In contrast with prepackaged
portion-controlled regular food, those
products contain essential nutrients
but generally lack bioactive food com-
ponents and do not illustrate how to
make good choices in response to food
exposures in grocery stores and restau-
rants. Additionally, behavioral counsel-
ing, education, frequent contact,
support, and increased physical activity,
elements incorporated in the program
examined in the current study, are de-
terminants of successful long-term
weight management (33,34) and are
recommended to promote long-term
weight management and glycemic con-
trol in diabetes care (3). Although
greater weight loss in response to a
lower versus higher carbohydrate diet
has been observed in insulin resistant,
nondiabetic individuals in a few previ-
ous studies (35,36), intention-to-treat
analysis did not reveal differential
weight loss in response to the two levels
of carbohydrate intake examined in
the current study. Previous studies
comparing a very-low-carbohydrate
diet with a low-fat diet in patients
with type 2 diabetes also did not report
differential effects on weight loss over
1–2 years (10,11,30). In those studies,
the very-low-carbohydrate diet re-
sulted in more favorable effects on car-
diovascular disease risk factors (e.g.,
HDL cholesterol and triglyceride levels),
as observed in the current study. A fa-
vorable effect on the level of CRP, an
inflammatory marker, also was ob-
served in response to participation in
the weight loss program in the current
study.
Table 3—Laboratory measurements
LF LC UC
Baseline 6 months 12 months Baseline 6 months 12 months Baseline 6 months 12 months
n 77 71 67 74 73 66 76 60 65
Glucose (mg/dL) 145 (44) 139 (40) 149 (59) 146 (52) 125 (32)* 133 (34) 145 (45) 148 (46)‡ 159 (60)†
HbA1c (%) 7.5 (1.2) 6.7 (1.0) 7.2 (1.5) 7.3 (1.4) 6.2 (0.8)* 6.6 (1.0)* 7.4 (1.1) 7.2 (1.5)‡ 7.5 (1.5)‡
HbA1c (mmol/mol) 58 (13) 50 (11) 55 (16) 56 (15) 44 (9)* 49 (11)* 57 (12) 55 (16)‡ 58 (16))‡
Insulin (mIU/mL) 29 (33) 22 (18) 25 (25) 27 (19) 19 (15) 18 (14) 33 (42) 29 (32)‡ 25 (19)†
Triglycerides (mg/dL) 172 (96) 150 (87) 156 (96) 177 (99) 137 (78) 140 (73) 181 (93) 181 (83)‡ 204 (123)‡
Total cholesterol (mg/dL) 155 (34) 158 (41) 168 (38) 153 (36) 157 (39) 164 (36) 161 (40) 168 (39) 170 (38)
HDL cholesterol (mg/dL) 37 (8) 46 (10) 51 (12) 39 (10) 48 (11) 54 (11) 39 (11) 46 (14) 49 (14)‡
LDL cholesterol (mg/dL) 80 (34) 82 (35) 86 (30) 79 (36) 81 (33) 83 (32) 83 (39) 86 (34) 81 (37)
CRP (mg/L) 4.2 (4.3) 3.6 (4.4) 2.3 (2.4) 3.5 (3.5) 2.7 (3.5) 2.0 (2.4) 4.2 (3.9) 3.6 (3.9)† 5.1 (9.1)‡
Total carotenoids
(mmol/L) 1.3 (0.5) d 1.9 (1.1) 1.4 (0.6) d 2.0 (1.0) 1.4 (1.1) d 1.6 (1.4)‡
Data aremean (SD). All models were controlled for sex. SI (International System of Units) conversion factors: To convert carotenoids tomg/dL, divide
by 0.01863; CRP to nmol/L, multiply by 9.524; HDL, LDL, and total cholesterol to mmol/L, multiply by 0.0259; triglycerides to mmol/L, multiply by
0.0113. *P , 0.05 compared with LF plan. †P , 0.05 compared with aggregated weight loss program intervention. ‡P , 0.01 compared with
aggregated weight loss program intervention.
Table 4—Medication use and change in medication use during the study
Medication type LF LC UC P value*
Diabetes (insulin) ,0.001
Baseline 19 10 12
Stopped/decreased 12 9 1
Started/increased 2 0 3
Diabetes (oral hypoglycemic) 0.007
Baseline 62 69 62
Stopped/decreased 24 22 10
Started/increased 6 6 8
Cholesterol 0.024
Baseline 49 52 57
Stopped/decreased 10 11 4
Started/increased 4 3 4
Hypertension 0.032
Baseline 52 65 60
Stopped/decreased 13 18 7
Started/increased 3 1 6
Data are counts. The counts shown are the number of participants reportingmedications in each
category at baseline and the number who at study end had changed dosage of one or more
medications in the category relative to baseline use. Those who substituted one medication for
another in the same category were not counted. *UC vs. weight loss program intervention.
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This study as some limitations. An im-
portant limitation is the lack of informa-
tion about adherence to the prescribed
diets. The target was a free-living popu-
lation, so variability in adherence is likely.
Self-reported dietary data have well-rec-
ognized limitations in accuracy, which are
characterized as substantial underreport-
ing and misreporting among overweight
and obese individuals. An implication of
this limitation is that it is not known
whether the more-favorable response in
those assigned to a lower-carbohydrate
diet may be due to better adherence or
even greaterweight loss, as was observed
among participants for whom data were
available at all time points. The interven-
tion and prepackaged foods were pro-
vided without cost to the participants,
as was also the case in Look AHEAD and
other weight loss and diet intervention
studies (4,31), which may affect general-
izability. Compared with the cost of a
comprehensive weight loss program, the
medical costs of type 2 diabetes that is
not optimally managed are considerable.
A larger proportion of participants in the
weight loss program (vs. the control con-
dition) in the current study was able to
reduce or discontinue diabetes, hyper-
tension, and lipid-lowering medications
and, thus, medical costs. Although aimed
toward prevention, the Diabetes Pre-
vention Program demonstrated that an
intensive lifestyle intervention is cost-
effective because of the high cost ofmed-
ical care associated with diabetes (37).
Another limitation is that the weight
loss program counselors were unblinded,
although they were instructed to provide
the program and services as delivered to
paying customers.
In summary, the structured weight
loss program resulted in greater weight
loss and improved glycemic control in
overweight or obese individuals with
type 2 diabetes compared with a UC
control group receiving less intensive
counseling.
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